Skip to main content

UBS Group AG

Position in CADL — Candel Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in CADL

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$734,289
+$144,774 QoQ
Shares Held
149,855
+43.6% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. CADL ranks #264 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $734,289 149,855
2025-12-31 $589,515 104,339
2025-09-30 $479,762 94,071
2025-06-30 $415,765 82,167
2025-03-31 $1,057,080 187,094
2024-12-31 $1,361,076 156,806
2024-09-30 $65,460 9,446
2024-06-30 $37,231 6,005
2024-03-31 $15 10
2023-12-31 $17,523 11,921
2023-09-30 $9 10
2023-06-30 $12 10
2023-03-31 $13 10
2022-12-31 $1,422 795
2022-09-30 $13,128 4,181
2022-06-30 $12,334 3,807
2022-03-31 $10,180 2,000
2021-12-31 $34,775 4,447
2021-09-30 $32,520 3,000